Gossamer Bio to present at Cantor Global Healthcare conference
Gossamer Bio, Inc. said it will present at the Cantor Global Healthcare Conference. The company is focused on seralutinib for pulmonary arterial hypertension (PAH) and PH-ILD.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.